2015
DOI: 10.1016/j.bmc.2015.04.079
|View full text |Cite
|
Sign up to set email alerts
|

Design, antiviral and cytostatic properties of isoxazolidine-containing amonafide analogues

Abstract: A novel series of 5-arylcarbamoyl- and 5-arylmethyl-2-methylisoxazolidin-3-yl-3-phosphonates have been synthesized via cycloaddition of N-methyl-C-(diethoxyphosphoryl)nitrone with N-substituted naphthalimide acrylamides and N-allylnaphthalimides. All cis- and trans-isoxazolidine phosphonates obtained herein were assessed for antiviral activity against a broad range of DNA and RNA viruses. Isoxazolidines trans-9d and trans-9f exhibited the highest activity (EC50=8.9μM) toward cytomegalovirus. Compounds cis- and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(9 citation statements)
references
References 31 publications
0
9
0
Order By: Relevance
“…135 Another class of 1,3-dipole that found attention in the synthesis of nucleoside analogs is that of nitrile oxides. Isoxazolidines trans-293A and trans-293B exhibited the highest activity (EC 50 5 8.9 μM) toward cytomegalovirus.…”
Section: Dielsàalder and Hetero Dielsàalder Reactions And The Antiviralsmentioning
confidence: 99%
“…135 Another class of 1,3-dipole that found attention in the synthesis of nucleoside analogs is that of nitrile oxides. Isoxazolidines trans-293A and trans-293B exhibited the highest activity (EC 50 5 8.9 μM) toward cytomegalovirus.…”
Section: Dielsàalder and Hetero Dielsàalder Reactions And The Antiviralsmentioning
confidence: 99%
“…The third generation synthetic topo II inhibitor 9-aminoanthracycline derivative amrubicin ( 10 , SM-5887) has been shown to have comparable efficacy to doxorubicin in adult soft tissue sarcoma (STS) without obvious cardiac toxicity in a phase II study . Acting as DNA intercalators, two naphthalimide derivatives, amonafide ( 11 , AS1413) and mitonafide ( 14 , NSC 300288), have been studied in phase III and phase II clinical trials, respectively. , …”
Section: Topo II Poisons and Catalytic Inhibitors/suppressorsmentioning
confidence: 99%
“…30 derivatives, amonafide (11, AS1413) and mitonafide (14, NSC 300288), have been studied in phase III and phase II clinical trials, respectively. 31,32 Resistance to chemotherapeutic drugs has been a major obstacle in cancer chemotherapy. Most topo II poisons have frequently suffered from MDR, which is related to the overexpression of MDR-associated proteins (i.e., P-gp, MDR1, MRP1, and BCRP), resulting in enhanced efflux of chemotherapeutic drugs out of the cells.…”
Section: Topo II Poisons and Catalyticmentioning
confidence: 99%
“…30,31 Naphthalimides with their unique photophysical properties such as large quantum yields, photostability and sizable Stokes shift, have been extensively used in both supramolecular and medicinal chemistry. 32 Naphthalimide exhibits a broad spectrum of biological applications such as antitumor activity which has been shown towards a variety of human and murine cells, 32 antibacterial, 33 antiviral, 34 analgesic, 35 antitrypanosomal, 36 etc. Apart from this, naphthalimide derivatives have been extensively utilized within non-biological applications such as optical brighteners, 37 fluorescent probes, 38 solar energy collectors 39 and laser dyes.…”
Section: Introductionmentioning
confidence: 99%